Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 525,000 | reported | 22 Jan 2019 | tx 4+2,450,000 |
| Vir Biotechnology, Inc. | 39,806 | reported | 27 May 2026 | tx 13+165,918 |
| Viridian Therapeutics, Inc.\DE | 25,000 | reported | 04 Feb 2021 | tx 4+73,000 |
| Design Source, Inc. | 12,500 | reported | 19 Jan 2018 | tx 2+37,500 |
| aTYR PHARMA INC | 1,428 | reported | 06 May 2020 | tx 5+93,428 |
| Vitae Pharmaceuticals, Inc | 0 | reported | 25 Oct 2016 | tx 32+343,557−1,033,685 |
| AMBIT BIOSCIENCES CORP | 0 | reported | 10 Nov 2014 | tx 2+14,000−14,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 22 May 2023 | GRANT_AWARD | Vir Biotechnology, Inc. | 6,027 | 0.00 USD | |
| 22 May 2023 | GRANT_AWARD | Vir Biotechnology, Inc. | 12,054 | 0.00 USD | deriv |
| 23 May 2022 | GRANT_AWARD | Vir Biotechnology, Inc. | 6,405 | 0.00 USD | |
| 23 May 2022 | GRANT_AWARD | Vir Biotechnology, Inc. | 12,810 | 0.00 USD | deriv |
| 21 May 2021 | GRANT_AWARD | Vir Biotechnology, Inc. | 3,374 | 0.00 USD | |
| 21 May 2021 | GRANT_AWARD | Vir Biotechnology, Inc. | 6,748 | 0.00 USD | deriv |
| 04 Feb 2021 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 25,000 | 0.00 USD | deriv |
| 09 Dec 2020 | GRANT_AWARD | Vir Biotechnology, Inc. | 46,500 | 0.00 USD | deriv |
| 21 May 2020 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 24,000 | 0.00 USD | deriv |
| 06 May 2020 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 19 Jun 2019 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12,000 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 22 Jan 2019 | GRANT_AWARD | Larimar Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 27 Jun 2018 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 12,000 | 0.00 USD | deriv |
| 15 May 2018 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 22 Feb 2018 | GRANT_AWARD | Larimar Therapeutics, Inc. | 275,000 | 0.00 USD | deriv |
| 19 Jan 2018 | GRANT_AWARD | Design Source, Inc. | 12,500 | 0.00 USD | deriv |
| 29 Dec 2017 | GRANT_AWARD | Larimar Therapeutics, Inc. | 1,100,000 | 0.00 USD | deriv |
| 09 Oct 2017 | GRANT_AWARD | Larimar Therapeutics, Inc. | 550,000 | 0.00 USD | deriv |